|
|
乳腺癌的二级预防研究进展
|
Abstract:
乳腺癌是世界范围内最常见的恶性肿瘤之一，对妇女的身体和心理造成了极大的危害。因此，开展乳腺癌的早期筛查能够有效地降低患者的死亡率，对于改善患者的预后和治疗效果非常关键。在乳腺癌的前期，由于没有任何的临床表现和体征，所以当发现和注意到的时候，往往都是中晚期，从而耽误了最佳的治疗时间，而且其预后也会大大地降低。为此，必须及时发现和诊断，减少病人病死率，改善病人的生存质量。该文对目前临床常用的几种乳腺癌的早期筛查技术进行了总结，并对其用于乳腺癌二级预防中的情况作了介绍，为今后的乳腺癌防治工作提供参考。
Breast cancer is one of the most common malignant tumors in the world, which has caused great harm to women’s physical and mental health. Therefore, early screening of breast cancer can effec-tively reduce the mortality of patients, which is critical to improve the prognosis and treatment ef-fect of patients. In the early stage of breast cancer, there are no clinical manifestations and signs, so when it is found and noticed, it is often in the middle and late stages, which delays the best treat-ment time, and its prognosis will be greatly reduced. Therefore, timely detection and diagnosis are necessary to reduce patient mortality and improve patient quality of life. This article summarized several commonly used early screening techniques for breast cancer, and introduced their applica-tion in secondary prevention of breast cancer, providing a reference for the prevention and treat-ment of breast cancer in the future.
| [1] | Sung, H., Ferlay, J., Siegel, R.L., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249.
https://doi.org/10.3322/caac.21660 |
| [2] | Fan, L., Strasser-Weippl, K., Li, J.J., et al. (2014) Breast Cancer in China. The Lancet Oncology, 15, E279-E289.
https://doi.org/10.1016/S1470-2045(13)70567-9 |
| [3] | 陈万青, 李霓, 石菊芳, 等. 中国城市癌症早诊早治项目进展[J]. 中国肿瘤, 2019, 28(1): 23-25. |
| [4] | 黄静, 杨湘红, 刘爱, 等. 农村地区妇女“两癌筛查”项目实施中的问题与对策[J]. 中国全科医学, 2020, 23(13): 1680-1686. |
| [5] | Siegel, R.L., Miller, K.D. and Jemal, A. (2020) Cancer Statistics, 2020. CA: A Cancer Journal for Clinicians, 70, 7-30.
https://doi.org/10.3322/caac.21590 |
| [6] | Chen, W., Xia, C., Zheng, R., et al. (2019) Disparities by Province, Age, and Sex in Site-Specific Cancer Burden Attributable to 23 Potentially Modifiable Risk Factors in China: A Comparative Risk Assessment. The Lancet Global Health, 7, E257-E269. https://doi.org/10.1016/S2214-109X(18)30488-1 |
| [7] | 张瑾, 陈薇, 刘蕾. 2017年《NCCN乳腺癌筛查和诊断临床实践指南》(第1版)更新与解读[J]. 中国全科医学, 2017, 20(24): 2939-2943. |
| [8] | 徐雅莉, 孙强, 单广良, 等. 中国女性乳腺癌发病相关危险因素: 病例对照研究[J]. 协和医学杂志, 2011, 2(1): 7-14. |
| [9] | Brem, R.F., Lenihan, M.J., Lieberman, J. and Torrente, J. (2015) Screening Breast Ultrasound: Past, Present, and Future. American Journal of Roentgenology, 204, 234-240. https://doi.org/10.2214/AJR.13.12072 |
| [10] | Oeffinger, K.C., Fontham, E.T.H., Etzioni, R., et al. (2015) Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update from the American Cancer Society. The Journal of the American Medical Association, 314, 1599-1614. https://doi.org/10.1001/jama.2015.12783 |
| [11] | 沈松杰, 孙强, 黄欣, 等. 中国女性乳腺癌筛查指南(2022年版) [J]. 中国研究型医院, 2022, 9(2): 6-13. |
| [12] | Garzotto, F., Comoretto, R.I., Michieletto, S., et al. (2021) Preoperative Non-Palpable Breast Lesion Localization, Innovative Tech-niques and Clinical Outcomes in Surgical Practice: A Systematic Review and Meta-Analysis. The Breast, 58, 93-105. https://doi.org/10.1016/j.breast.2021.04.007 |
| [13] | O’Grady, S. and Morgan, M.P. (2018) Microcalcifications in Breast Cancer: From Pathophysiology to Diagnosis and Prognosis. Biochimica et Biophysica Acta (BBA)—Reviews on Cancer, 1869, 310-320.
https://doi.org/10.1016/j.bbcan.2018.04.006 |
| [14] | 隋旭蕾, 唐小锋. 数字化乳腺摄影评价无肿块型乳腺癌微钙化的研究进展[J]. 医学影像学杂志, 2018, 28(1): 148-150. |
| [15] | Kalambo, M., Dogan, B.E. and Whitman, G.J. (2020) Step by Step: Planning a Needle Localization Procedure. Clinical Imaging, 60, 100-108. https://doi.org/10.1016/j.clinimag.2019.12.007 |
| [16] | Siu, A.L. and U.S. Preventive Services Task Force (2016) Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement. Annals of Internal Medi-cine, 164, 279-296. https://doi.org/10.7326/M15-2886 |
| [17] | Ohuchi, N., Suzuki, A., Sobue, T., et al. (2016) Sensi-tivity and Specificity of Mammography and Adjunctive Ultrasonography to Screen for Breast Cancer in the Japan Strate-gic Anti-Cancer Randomized Trial (J-START): A Randomised Controlled Trial. The Lancet, 387, 341-348. https://doi.org/10.1016/S0140-6736(15)00774-6 |
| [18] | Tagliafico, A.S., Calabrese, M., Mariscotti, G., et al. (2016) Adjunct Screening with Tomosynthesis or Ultrasound in Women with Mammography-Negative Dense Breasts: Interim Report of a Prospective Comparative Trial. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 34, 1882-1888.
https://doi.org/10.1200/JCO.2015.63.4147 |
| [19] | Berg, W.A., Zhang, Z., Lehrer, D., et al. (2012) Detection of Breast Cancer with Addition of Annual Screening Ultrasound or a Single Screening MRI to Mammography in Women with Elevated Breast Cancer Risk. The Journal of the American Medical Association, 307, 1394-1404. https://doi.org/10.1001/jama.2012.388 |
| [20] | Shen, S., Zhou, Y., Xu, Y., et al. (2015) A Multi-Centre Randomised Trial Comparing Ultrasound vs Mammography for Screening Breast Cancer in High-Risk Chinese Women. British Journal of Cancer, 112, 998-1004.
https://doi.org/10.1038/bjc.2015.33 |
| [21] | Wang, F.L., Chen, F., Yin, H., et al. (2013) Effects of Age, Breast Densi-ty and Volume on Breast Cancer Diagnosis: A Retrospective Comparison of Sensitivity of Mammography and Ultraso-nography in China’s Rural Areas. Asian Pacific Journal of Cancer Prevention, 14, 2277-2282. |
| [22] | 闫晔. 中国女性乳腺腺体密度分布及其影响因素的研究[D]: [博士学位论文]. 天津: 天津医科大学, 2014. |
| [23] | 张金英, 戚元刚, 李云. 乳腺X线摄影和超声检查与MRI在乳腺癌诊断中的价值分析[J]. 医学影像学杂志, 2017, 27(12): 2306-2309. |
| [24] | Peters, N.H.G.M., Borel Rinkes, I.H.M., Zuithoff, N.P.A., et al. (2008) Meta-Analysis of MR Imag-ing in the Diagnosis of Breast Lesions. Radiology, 246, 116-124. https://doi.org/10.1148/radiol.2461061298 |
| [25] | Geuzinge, H.A., Obdeijn, I.M., Rutgers, E.J.T., et al. (2020) Cost-Effectiveness of Breast Cancer Screening with Magnetic Resonance Imaging for Women at Familial Risk. JAMA Oncology, 6, 1381-1389.
https://doi.org/10.1001/jamaoncol.2020.2922 |
| [26] | Whitaker, K.D., Sheth, D. and Olopade, O.I. (2020) Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Risk-Stratified Screening in Women with BRCA Mutations or High Familial Risk for Breast Cancer: Are We There Yet? Breast Cancer Research and Treatment, 183, 243-250. https://doi.org/10.1007/s10549-020-05759-3 |
| [27] | Mann, R.M., Cho, N. and Moy, L. (2019) Breast MRI: State of the Art. Radiology, 292, 520-536.
https://doi.org/10.1148/radiol.2019182947 |
| [28] | Lu, J., Zhou, P., Jin, C., et al. (2020) Diagnostic Value of Con-trast-Enhanced Ultrasonography with SonoVue in the Differentiation of Benign and Malignant Breast Lesions: A Me-ta-Analysis. Technology in Cancer Research & Treatment, 19. https://doi.org/10.1177/1533033820971583 |
| [29] | 雷凡, 李倩. 超声造影对乳腺良恶性结节的鉴别诊断效能分析[J]. 现代医学与健康研究电子杂志, 2022, 6(22): 111-114. |
| [30] | Schneider, B.P. and Miller, K.D. (2005) Angiogenesis of Breast Cancer. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 23, 1782-1790. https://doi.org/10.1200/JCO.2005.12.017 |
| [31] | 杜晶, 李凤华, 方华, 等. 超声造影微血管成像评估乳腺肿瘤血管形态及分布特征[J]. 中华超声影像学杂志, 2007, 16(9): 773-776. |
| [32] | 贾静怡, 范小晶, 王川予, 等. 超声引导经皮微波消融治疗乳腺多发良性结节的疗效[J]. 中国医学影像学杂志, 2021, 29(4): 325-328, 331. |
| [33] | 刘俊, 但强. 超声造影在乳腺癌前哨淋巴结中的诊断价值及准确性分析[J]. 影像研究与医学应用, 2021, 5(22): 32-33. |
| [34] | Manca, G., Rubello, D., Tardelli, E., et al. (2016) Sentinel Lymph Node Biopsy in Breast Cancer: Indica-tions, Contraindications, and Controversies. Clinical Nuclear Medicine, 41, 126-133.
https://doi.org/10.1097/RLU.0000000000000985 |
| [35] | 邹淑丽, 吴在龙, 张金蕊, 等. 超声引导下细针穿刺活检与弹性成像在诊断乳腺肿块中的应用价值[J]. 医学影像学杂志, 2020, 30(3): 393-396. |
| [36] | 周利勇, 刘剑仑, 蒋奕. B超引导细针穿刺活检术在乳腺癌腋窝淋巴结转移中的诊断价值[J]. 广西医学, 2019, 41(5): 541-544. |
| [37] | 张岳宇, 孔繁云, 陈成辉. 超声征象对超声引导下穿刺活检在早期乳腺癌中诊断价值的影响[J]. 中国普通外科杂志, 2019, 28(9): 1165-1170. |
| [38] | 中国医师协会精准治疗委员会乳腺癌专业委员会, 中华医学会肿瘤学分会乳腺肿瘤学组, 中国抗癌协会乳腺癌专业委员会, 等. 中国乳腺癌患者BRCA1/2基因检测与临床应用专家共识(2018年版) [J]. 中国癌症杂志, 2018, 28(10): 787-800. |
| [39] | Castéra, L., Krieger, S., Rousselin, A., et al. (2014) Next-Generation Sequencing for the Diagnosis of Hereditary Breast and Ovarian Cancer Using Genomic Capture Tar-geting Multiple Candidate Genes. European Journal of Human Genetics, 22, 1305-1313. https://doi.org/10.1038/ejhg.2014.16 |
| [40] | Nielsen, F.C., Van Overeem Hansen, T. and S？rensen, C.S. (2016) He-reditary Breast and Ovarian Cancer: New Genes in Confined Pathways. Nature Reviews Cancer, 16, 599-612. https://doi.org/10.1038/nrc.2016.72 |
| [41] | Yang, P.S., Lee, Y.H., Chung, C.F., et al. (2019) A Preliminary Report of Head-to-Head Comparison of 18-Gene-Based Clinical-Genomic Model and Oncotype DX 21-Gene Assay for Predicting Recurrence of Early-Stage Breast Cancer. Japanese Journal of Clinical Oncology, 49, 1029-1036. https://doi.org/10.1093/jjco/hyz102 |
| [42] | Hamidi, A.A., Zangoue, M., Kashani, D., et al. (2022) MicroRNA-217: A Therapeutic and Diagnostic Tumor Marker. Expert Review of Molecular Diagnostics, 22, 61-76. https://doi.org/10.1080/14737159.2022.2017284 |
| [43] | 康鑫崴, 李祥哲, 刘杰. 计算机断层扫描联合血清肿瘤标志物检测在胰腺癌诊断中的应用价值分析[J]. 癌症进展, 2020, 18(21): 2187-2190. |
